Enter company name or symbol or keyword from report title or report description. You can also use our advanced search option to further filter your results.
Register NowLogin to receive $10 worth of FREE credit. This offer is valid for limited time.
984 (79%) - Correct 255 (21%) - Incorrect
Explanation
Recent News on Covered Stocks
VVUS
THLD
CORT
CTIC
NGSX
Titan Pharmaceuticals, Inc. (TTNP) - Historical Event - February 2012
Probuphine for Opioid Addiction (Phase III Open-label trial)
Phase III Open-label trial data of Probuphine for opioid addiction
- Price: $10.00 Add to cart Mail to friend Add to favorite
VRTX's HCV drug Telaprevir received FDA approval on May 23, 2011. New BioMedicine had issued a report on this event on May 3, 2011. To read more about the drug, the disease, the market, the competition, etc. access it at the link below.
Specific theme-based reports at a value price
©Copyright 2012 New Bio Medicine, LLC. All Right Reserved.
